ArticleBiophysical reviews2022
Biophysical Reviews: focusing on an issue.
Article in Biophysical reviews, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Biophysical Reviews: focusing on an issue.Biophysical reviews · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This Issue of Biophysical Reviews (Volume 14, Issue 2) presents a new feature known as an 'Issue Focus' - a contiguous thematic block of five articles placed within a regular Issue format. The current 'Issue Focus' is concerned with the recent developments in Costa Rican biophysical science. The regular aspect of this Issue consists of a 'Meet the Editor' piece by Sabrina Leslie, the first instalment of an ongoing Commentary feature known as the 'Editors' Roundup', and five disparate review articles covering a variety of topics.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.